- Home
- NTCT vs KYMR Comparison
NTCT vs KYMR Comparison
Compare NTCT & KYMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NTCT
- KYMR
- Stock Information
- Founded
- NTCT 1984
- KYMR 2015
- Country
- NTCT United States
- KYMR United States
- Employees
- NTCT N/A
- KYMR N/A
- Industry
- NTCT EDP Services
- KYMR Medicinal Chemicals and Botanical Products
- Sector
- NTCT Technology
- KYMR Health Care
- Exchange
- NTCT Nasdaq
- KYMR Nasdaq
- Market Cap
- NTCT 1.7B
- KYMR 1.8B
- IPO Year
- NTCT 1999
- KYMR 2020
- Fundamental
- Price
- NTCT $22.84
- KYMR $29.64
- Analyst Decision
- NTCT Hold
- KYMR Buy
- Analyst Count
- NTCT 1
- KYMR 15
- Target Price
- NTCT $25.00
- KYMR $55.47
- AVG Volume (30 Days)
- NTCT 443.4K
- KYMR 650.3K
- Earning Date
- NTCT 05-08-2025
- KYMR 05-09-2025
- Dividend Yield
- NTCT N/A
- KYMR N/A
- EPS Growth
- NTCT N/A
- KYMR N/A
- EPS
- NTCT N/A
- KYMR N/A
- Revenue
- NTCT $822,679,000.00
- KYMR $58,885,000.00
- Revenue This Year
- NTCT $3.29
- KYMR $32.80
- Revenue Next Year
- NTCT $2.93
- KYMR $8.88
- P/E Ratio
- NTCT N/A
- KYMR N/A
- Revenue Growth
- NTCT N/A
- KYMR N/A
- 52 Week Low
- NTCT $17.10
- KYMR $19.45
- 52 Week High
- NTCT $27.89
- KYMR $53.27
- Technical
- Relative Strength Index (RSI)
- NTCT 55.83
- KYMR 48.27
- Support Level
- NTCT $22.79
- KYMR $28.06
- Resistance Level
- NTCT $23.63
- KYMR $30.28
- Average True Range (ATR)
- NTCT 0.54
- KYMR 1.65
- MACD
- NTCT -0.04
- KYMR -0.19
- Stochastic Oscillator
- NTCT 42.26
- KYMR 27.96
About NTCT NetScout Systems Inc.
NetScout Systems Inc is a provider of service assurance and cybersecurity solutions to enterprise and government networks. It bases its solutions on proprietary adaptive service intelligence technology, which helps customers monitor and identify performance issues and provides insight into network-based security threats. These solutions also deliver real-time and historical information, which provides insight to restore service and understand the quality of user experience. The company derives revenue from the sale of network management tools and security solutions. Its geographical regions include USA, which derives maximum revenue, Europe, Asia, and Rest of the World.
About KYMR Kymera Therapeutics Inc.
Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of, differentiated medicines that address health problems and that meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, TYK2, and IRAK4.